Mật độ khoáng xương ở nam giới nhiễm virus HIV-1 với tình trạng thiểu năng sinh dục trước khi điều trị bằng thuốc kháng retrovirus hoạt động mạnh (HAART)

Zaloga GP, Chernow B: The multifactorial basis for hypocalcemia during sepsis studies of parathyroid hormone-vitamine D axis. Ann Int Med 1987, 107: 36–41. Kuehn EW, Anders HJ, Bogner JR, Obermaier J, Goebel FD, Schlöndorff D: Hypocalcaemia in HIV-infection and AIDS. J Intern Med 1999, 245: 69–73. 10.1046/j.1365-2796.1999.00407.x Dluhy RG: The growing spectrum of HIV-releated endocrine abnormalities. J Clin Endocrinol Metab 1990, 70: 563–565. Glass AR, Eil C: Ketoconazole-induced reduction in serum 1,25-dihydroxy-vitamin D, total serum calcium in hypercalcemic patients. J Clin Endocrinol Metab 1988, 66: 934–938. 10.1210/jcem-66-5-934 Jacobs MB: The aquired immune deficiency syndrome and hypercalcemia. West J Med 1986, 114: 467–471. Pont A: Unusual causes of hypercalcemia. Endocrinol Metabol Clin North Am 1989, 18: 753–764. Hernandez Quero J, Centeno NO, Munoz-Torres M, Martinez-Perez A, Higuera Torres-Puchol JM: Alterations in bone turnover in HIV-positive patients. Infection 1993, 21: 220–222. 10.1007/BF01728893 Serrano M, Marinoso JC, Soriano JC, Rubies-Prat J, Aubia J, Coll J, Bosch J, Del Rio L, Vila J, Goday A, Nacher M: Bone remodeling in human immunodeficiency virus-1–1 infected patients. A histomorphometric Study. Bone 1995, 16: 185–191. 10.1016/8756-3282(94)00028-X Teichmann J, Stephan E, Discher T, Lange U, Federlin K, Stracke H, Friese G, Lohmeyer J, Bretzel RG: Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism 2000, 49: 1134–1139. 10.1053/meta.2000.8609 Paton NIJ, Macallan DC, Griffin GE, Pazianas M: Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 1997, 61: 30–32. 10.1007/s002239900288 Tebas P, Powderly WG, Claxton S, Marin D, Tantisriwat T, Teitelbaum SL, Yarasheski KE: Accelerated bone and mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000, 14: 63–67. Carr A, Miller J, Eisman JA, Cooper DA: Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 2001, 15: 703–709. 10.1097/00002030-200104130-00005 Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN, Studd JW, Johnson MA: Reduced bone mineral density in HIV-positive individuals. AIDS 2001, 15: 1731–1733. 10.1097/00002030-200109070-00019 Manalogas SC, Jilka RL: Bone marrow, cytokines, and bone remodelling. Emerging insights into pathophysiology of osteoporosis. N Engl J Med 1995, 332: 529–534. 10.1056/NEJM199502233320809 Orwoll ES, Klein RF: Osteoporosis in men. Endocrin Rev 1995, 16: 87–116. Horowitz MC: Cytokines and estrogen in bone: Antiosteoporotic effects. Science 1993, 260: 626–627. 10.1126/science.8480174 Dobbs AS, Demsey MA, Ladenson PW, Polk BF: Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988, 84: 611–616. 10.1016/0002-9343(88)90144-1 Youle MS: Severe hypocalcemia in AIDS patients treated with foscarnet and pentamidine. Lancet 1988, 331: 1455–1456. 10.1016/S0140-6736(88)92260-X Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA: Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 1991, 72: 1130–1135. 10.1210/jcem-72-5-1130 Bühl A, Zöfel P: SPSS für Windows Version 6. Addison-Wesley; 1994. Fairfield WP, Finkelstein JS, Klibanski A, Grinspon SK: Osteopenia in eugonadal men with acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 2001, 86: 2020–2026. 10.1210/jc.86.5.2020 Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M: Testosterone supplementation of megestrol therapy d oes not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 2007, 92: 563–570. Rietschel P, Corcoran C, Stanlay T, Basgoz N, Klibanski A, Grinspoon SK: Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were received highly active antiretroviral therapy. Clin Infect Dis 2000, 31: 1240–1244. 10.1086/317457 Mylonakis E, Koutkia P, Grinspoon SK: Diagnosis and treatment of androgen-deficiency in human immunodeficiency virus-infected men and women. Clin Infect Dis 2001, 15: 857–864. Huang JS, Wilkie SJ, Sullivan MP, Grinspoon S: Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting. J Endocrinol Metab 2001, 86: 3533–3539. 10.1210/jc.86.8.3533 McNurlan MA, Garlick PJ, Frost RA, Decristofaro KA, Lang CH, Steigbigel RT, Fuhrer J, Gelato M: Albumin synthesis and bone kollagen formation in human immunodeficiency virus-positive subjects. Differential effects of growth hormone administration. J Clin Endocrinol Metab 1999, 83: 3050–3055. Aukrust P, Haug CJ, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Froland SS: Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Inivation of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 1999, 84: 145–150. 10.1210/jc.84.1.145 Aukrust P, Liabakk NB, Müller F, Lien E, Froland SS: Serum levels of tumor necrosis factor (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994, 169: 420–424. 10.1093/infdis/169.2.420 Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000, 15: 2–12. 10.1359/jbmr.2000.15.1.2 Haug C, Müller F, Aukrust P, et al.: Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with the degree of immunedeficiency and survival. J Infect Dis 1994, 169: 889–893. 10.1093/infdis/169.4.889 Jaeger Ph, Otto ST, Speck RF, Villiger L, Horber FF, Casez JP, Takkinen R: Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 1994, 79: 1701–1705. 10.1210/jc.79.6.1701 Pedrazzoni M, Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, Alfano FS, Passeri M: Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol 1993, 93: 42–44. Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S: Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 2001, 15: 1275–1280. 10.1097/00002030-200107060-00009 Klein R, Lo Y, Santoro N, Dobs A: Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 2005, 41: 57–66. 10.1086/432890 Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, Brandt C, Pope B, Furtek K, Medina S, Wallace MR: Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007, 21: 9–19. 10.1089/apc.2006.0071 Mondy K, Yarashekski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evaliation of bone mineral density and bone markers in human imunodeficiency virus infected individuals. Clin Infect Dis 2003, 36: 482–490. 10.1086/367569 Bhasin S, Cunningham GR, Haves FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM: Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006, 91: 1995–2010. 10.1210/jc.2005-2847 Grinspoon S: Androgen deficiency and HIV Infection. Clin Infect Dis 2005, 41: 1804–1805. 10.1086/498320 Clay PG, Voss LE, Williams C, Daume EC: Valid treatment options for osteoporosis and osteopenia in HIV-infected persons. Ann Pharmacother 2008, 42: 670–679. 10.1345/aph.1K465